Chemokines in Respiratory Viral Infections: Focus on Their Diagnostic and Therapeutic Potential

被引:9
作者
Amanatidou, Virginia [1 ]
Zaravinos, Apostolos [1 ]
Apostolakis, Stavros [1 ]
Spandidos, Demetrios A. [1 ]
机构
[1] Univ Crete, Fac Med, Lab Clin Virol, Iraklion 71110, Crete, Greece
关键词
respiratory tract; viral infection; chemokines; therapeutic target; SYNCYTIAL VIRUS-INFECTION; CYTOKINE RESPONSES; CYTOKINE/CHEMOKINE PROFILES; RHEUMATOID-ARTHRITIS; AIRWAY INFLAMMATION; PULMONARY INFECTION; IMMUNE-RESPONSE; GENE-EXPRESSION; DENDRITIC CELLS; INFLUENZA-VIRUS;
D O I
10.1615/CritRevImmunol.v31.i4.40
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chemokines are small chemoattractant cytokines involved in cell trafficking and activation. Despite the general nonspecific nature of chemokine activity in certain instances, specific chemokine expression patterns have been associated with specific disease states. In the field of respiratory viral infection, evidence suggests that response to viral invasion is regulated by a distinct chemokine expression profile involving more CC chemokines than CXC chemokines. Moreover, among the CC chemokines, CCL3 and CCL5 appear to be most commonly implicated in viral respiratory disease. Most data available in this field have been derived from in vitro studies, as well as studies conducted in animal models with limited evidence obtained in settings of actual human disease. In the present review, we focus on the diagnostic, prognostic, and therapeutic potential of virus-induced chemokine activity as reflected by studies conducted in actual disease states, either in animal models or humans. We further discuss whether these data advocate chemokines as a realistic clinical tool for the management of viral infection.
引用
收藏
页码:341 / 356
页数:16
相关论文
共 91 条
[71]  
TAYLOR G, 1984, INFECT IMMUN, V43, P649, DOI 10.1128/IAI.43.2.649-655.1984
[72]   Heterogeneity in control of mRNA stability by AU-rich elements [J].
Tebo, J ;
Der, S ;
Frevel, M ;
Khabar, KSA ;
Williams, BRG ;
Hamilton, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (14) :12085-12093
[73]  
Tekkanat KK, 2002, EUR J IMMUNOL, V32, P3276, DOI 10.1002/1521-4141(200211)32:11<3276::AID-IMMU3276>3.0.CO
[74]  
2-5
[75]   CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein [J].
Tripp, RA ;
Jones, LP ;
Haynes, LM ;
Zheng, HQ ;
Murphy, PM ;
Anderson, LJ .
NATURE IMMUNOLOGY, 2001, 2 (08) :732-738
[76]   Pathogenesis of respiratory syncytial virus infection [J].
Tripp, RA .
VIRAL IMMUNOLOGY, 2004, 17 (02) :165-181
[77]   Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA [J].
Tripp, RA ;
Moore, D ;
Barskey, A ;
Jones, L ;
Moscatiello, C ;
Keyserling, H ;
Anderson, LJ .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (10) :1388-1394
[78]   Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice [J].
Tripp, RA ;
Moore, D ;
Jones, L ;
Sullender, W ;
Winter, J ;
Anderson, LJ .
JOURNAL OF VIROLOGY, 1999, 73 (09) :7099-7107
[79]   Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice [J].
Tripp, RA ;
Moore, D ;
Winter, J ;
Anderson, LJ .
JOURNAL OF VIROLOGY, 2000, 74 (04) :1614-1622
[80]   Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse [J].
Tripp, RA ;
Jones, L ;
Anderson, LJ .
JOURNAL OF VIROLOGY, 2000, 74 (13) :6227-6229